Gastrodex

Quick links to important sections

Gastrodex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gastrodex

Property Description
Active Ingredient Lansoprazole (INN)
Form Delayed-release capsules (Oral)
Pharmacological Class Proton Pump Inhibitor (PPI)
General Purpose Gastric Acid Suppression
Origin Synthetic Compound

Definition and Pharmacological Classification

Gastrodex is an anti-secretory medication containing the active ingredient Lansoprazole, which is a synthetic compound classified as a Proton Pump Inhibitor (PPI). This class of drug is clinically recognized for achieving potent and sustained reduction in the production of gastric acid. The generic entity, Lansoprazole, belongs chemically to the Substituted Benzimidazoles. This medication is designated for use in individuals requiring consistent and reliable control over stomach acid levels.

Composition, Form, and General Purpose

Gastrodex is formulated for oral administration, typically as delayed-release capsules. This specialized form is critical because the active component, Lansoprazole, is highly susceptible to destruction by the stomach's acidic environment. The capsules contain tiny enteric-coated pellets, designed to ensure the drug survives the stomach and is released effectively into the small intestine for absorption.

The primary therapeutic purpose of Gastrodex is gastric acid suppression. By consistently blocking the final step of acid secretion, the medicine functions as an antiulcerative agent, reducing the caustic effects of acid on the digestive lining. This sustained reduction in acid allows damaged tissues, such as those in the esophagus or stomach, a necessary period of low-acid exposure to heal and recover.

Regulatory References

  1. Lansoprazole MedlinePlus Drug Information

What side effects are possible with Gastrodex?

Possible Side Effects and Safety Information

The safety profile of Gastrodex (Lansoprazole) is formally classified based on frequency and the physiological system affected, according to regulatory standards from government authorities. This classification helps define the officially documented risks associated with the medicine's use.


Adverse Reactions by Official Frequency Classification

Adverse reactions are grouped by their incidence as reported in official prescribing information:

  • Common Reactions: These are the most frequently reported effects and may include diarrhea, abdominal pain, nausea, and headache.
  • Uncommon Reactions: Effects reported less frequently include dizziness, depression, rash, joint pain (arthralgia), and elevations in liver enzyme levels.
  • Rare and Very Rare Reactions: These infrequent events encompass conditions such as certain blood disorders (e.g., thrombocytopenia), fever, pancreatitis, and severe skin reactions like Stevens-Johnson Syndrome (SJS).

Serious Safety Considerations and Long-Term Patterns

Official regulatory documentation highlights specific serious adverse reactions. These include Acute Tubulointerstitial Nephritis, a form of kidney inflammation, and an increased risk of developing Clostridium difficile-Associated Diarrhea (CDAD).

Risks explicitly tied to prolonged use (typically one year or longer) include Hypomagnesaemia (low blood magnesium levels) and an increased risk of bone fracture in the hip, wrist, or spine. Additionally, long-term daily use may be associated with the development of Fundic Gland Polyps.


Population-Specific Constraints

The official label states that use is generally not recommended in pediatric patients under one year of age. Caution is required when the medicine is used in patients with moderate or severe hepatic impairment, as drug exposure may be increased in this group.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Gastrodex requires immediate, urgent medical attention. Overdosage may be life-threatening and can present a range of symptoms, particularly affecting the central nervous system, cardiovascular, and respiratory systems. Symptoms reported in association with high drug levels or improper exposure can range from mild effects to severe toxicity.

Documented Overdose Presentations

Physiological System Reported Manifestations
Central Nervous System Altered mental status (agitation, confusion, coma), seizures, hallucinations, ataxia, and muscular rigidity.
Cardiovascular Bradycardia (slow heart rate), tachycardia (rapid heart rate), hypertension (high blood pressure), and hypotension (low blood pressure).
Respiratory Respiratory depression, bradypnoea (slow breathing), or difficulty breathing.
Other Hyperthermia (raised body temperature), diaphoresis, mydriasis, nystagmus, and miosis.

Risk Factors and Emergency Action

Overdose risk is elevated with high dose levels, accidental ingestion (especially in children due to improper dose preparation), co-administration with other central nervous system depressants, or failure to adjust the dose in individuals with known renal impairment. Serious complications such as organ toxicity or prolonged hemodynamic instability have been reported.

If an overdose is suspected, seek emergency medical services (e.g., call 911) immediately. A prolonged period of observation and supportive care may be necessary to manage symptoms and vital functions due to potential toxicity. Do not delay seeking medical help.

Therapeutic Uses of Gastrodex

What Gastrodex Treats: Main Uses and Benefits

Gastrodex is commonly used to provide symptomatic support for symptoms related to physical discomfort and functional digestive issues, applied across domains where additional symptomatic support is needed. The medication is applied in addressing symptom clusters that interfere with daily comfort, such as occasional bloating, gas, and irregularity. The therapeutic domain of this category of medicine is well-established for managing conditions where functional stability becomes affected.

The product is generally used in situations involving certain distressing symptoms and often used during phases when symptoms become more noticeable. This supportive relief helps maintain a sense of stability when symptoms are more noticeable, contributing to improved comfort during periods of heightened symptoms.


“Gastrodex is commonly used in situations involving certain distressing symptoms linked to temporary digestive discomfort.”

Quick Fact: Focus on Symptoms related to Physical Discomfort

(Gastrodex is commonly used to help with symptoms of physical discomfort, supporting patients during episodes of heightened discomfort.)

Regulatory References

  1. NHS guidance on treatments for bloating and constipation

Eligibility and Restrictions for Use

Who Can and Cannot Use Gastrodex?

This section defines the official population eligibility and non-eligibility criteria for Gastrodex (Lansoprazole), as stated in governmental regulatory documents.


Absolute Contraindications

Gastrodex is contraindicated and must not be used by patients with a known severe hypersensitivity to the drug or any component of the formulation. Use is also contraindicated in patients who are concurrently taking a product containing rilpivirine.


Age and Physiological Restrictions

Population Group Regulatory Status Restriction Context
Adults (18+) Eligible Approved for labeled uses.
Pediatric (1–17 years) Eligible Approved for symptomatic GERD and erosive esophagitis.
Infants (< 1 year) Not Recommended Found to be not effective for symptomatic GERD in this age group.
Pregnancy/Lactation Restricted Use Use is not usually recommended due to limited human data; excretion into breast milk is unknown.

Condition-Based Limitations

Patients with severe hepatic impairment (severe liver disease) should be monitored closely, and a dose adjustment should be considered by a healthcare professional due to altered drug clearance. No dose adjustment is specified for renal impairment. The orally disintegrating tablet form (ODT) is restricted for patients with Phenylketonuria (PKU).

What should I know about interactions with other medicines?

Gastrodex, which contains aluminum and magnesium hydroxides (antacids), can interact with many other medications by altering their absorption in the stomach. The change in stomach pH can reduce or increase how much of the co-administered drug enters the bloodstream, potentially affecting its effectiveness or toxicity.

Drugs Requiring Spacing

Many medications must be separated from Gastrodex administration by at least two hours to prevent reduced absorption. This includes:

  • Certain antibiotics (e.g., tetracyclines and fluoroquinolones like ciprofloxacin)
  • Iron supplements (e.g., ferrous sulfate) and multivitamins that contain iron
  • Some heart medications (e.g., digoxin)
  • Thyroid hormones (e.g., levothyroxine)
  • Bisphosphonates (for osteoporosis)

Other Notable Interactions

  • Citrate-Containing Products: Concomitant use with products containing citrate (found in some effervescent tablets, soft drinks, and fruit juices) can significantly increase aluminum absorption from Gastrodex, posing a risk of aluminum toxicity, particularly in patients with kidney impairment.
  • Magnesium-Containing Products: Combining Gastrodex with other magnesium-containing laxatives or supplements may increase the risk of magnesium overdose, especially for those with reduced kidney function.

Mechanism of Action

Gastrodex is a competitive antagonist of the H2 histamine receptor expressed on the basolateral membrane of gastric parietal cells. In the absence of Gastrodex, endogenous histamine binding activates a Gs protein, which stimulates adenylyl cyclase and increases intracellular levels of cyclic AMP ( cAMP). This cAMP signaling cascade subsequently regulates the activity of the H^+/ K^+-ATPase (proton pump) located on the apical membrane, which is responsible for gastric acid secretion. By binding to the H2 receptor, Gastrodex inhibits the histamine-dependent increase in cAMP signaling in the parietal cell. This molecular action results in a reduction of H^+/ K^+-ATPase activity, which modulates the volume and lowers the pH of the gastric lumen.

Dosage and Administration Information

How to Use Gastrodex

Gastrodex (Lansoprazole) is administered primarily through the oral route using delayed-release capsules or oral suspension. The general principles of administration are based on the need to protect the drug from stomach acid, correct timing, and adherence to established dosing schedules.

Usage Domain Official Administration Rule
Dosing Frequency Typically once daily (q.d.), taken at the same time each day. Twice-daily dosing is reserved for specific multi-drug regimens, such as H. pylori eradication.
Dosing Range Standard adult oral doses are 15 mg or 30 mg per day. High-dose regimens, such as for Zollinger-Ellison Syndrome, may start at 60 mg once daily, with doses over 120 mg daily administered in divided doses.
Timing Relative to Meals Oral forms must be taken before a meal, ideally in the morning before breakfast. Taking the dose with food may significantly reduce the amount of drug absorbed.
Form Integrity Delayed-release capsules must be swallowed whole; they must not be crushed or chewed. This is a mandatory condition for preserving the enteric coating that allows the active ingredient to pass through the stomach intact.
Special Handling For patients who cannot swallow the capsule, it is permitted to open the capsule and the intact pellets can be sprinkled onto soft foods, such as applesauce, or mixed with specific fruit juices for immediate consumption.
Population Adjustment While no routine dose adjustment is needed for older adults, consideration is given to a dose reduction in patients with severe hepatic (liver) impairment.

Recent Clinical Evidence

Evidence for Symptomatic Relief of Upper Abdominal Discomfort

This section will summarize the available evidence base, focusing on the randomized controlled trials (RCTs) and systematic reviews that have explored the medicine in research settings evaluating symptom patterns related to functional dyspepsia (FD) and related upper abdominal discomfort. The research examined studies evaluating patient-reported experiences of physical discomfort in adults diagnosed with FD, a condition characterized by fluctuating or episodic manifestations.

Studies reported patterns that were observed, particularly in patients classified in the Epigastric Pain Syndrome subgroup. Research monitored patterns related to symptom changes, but across the broader evidence landscape, studies reported mixed findings when measuring the outcome of complete symptom resolution.


Study Design and Outcomes Examined

The research examined the medicine using rigorous methods, primarily consisting of short-term RCTs that were double-blind and placebo-controlled. Studies explored outcomes related to physical discomfort and changes in the severity of specific symptoms. The populations studied were typically adult patients with FD. Research provides context; however, findings describe group patterns and do not provide individual predictions.


What is Still Being Studied or Remains Uncertain

The consistency of the research varies across studies, and the findings were mixed, which contributes to the fact that certainty remains low for the symptomatic use in FD. The follow-up durations for efficacy trials were generally limited to four to eight weeks. Therefore, limited information is available regarding long-term outcomes, and the durability of any observed changes is not fully established. A key limitation noted is the limited or absent evaluation of outcomes for symptoms such as postprandial fullness and bloating in some of the key trials. Data for specific groups, such as older adults, remain insufficient.

Key Studies & References

  1. Systematic Review: Proton pump inhibitors for the treatment of functional dyspepsia
  2. Randomized Controlled Trial of Lansoprazole vs. Placebo in Subgroups of Functional Dyspepsia
  3. American College of Gastroenterology (ACG) Guideline on the Management of Functional Dyspepsia
  4. FDA Approved Labeling for Lansoprazole (Delayed-Release Capsules) - Clinical Studies Section

Frequently Asked Questions (FAQ)

Common questions about Gastrodex (FAQ)

Q: Is Gastrodex used to treat specific stomach conditions or a wider range of issues?

A: Official regulatory documents indicate that Gastrodex (Lansoprazole) is approved for the treatment of specific diagnosed conditions. These include healing erosive esophagitis, managing symptomatic gastroesophageal reflux disease (GERD), treating active duodenal ulcers, and managing certain hypersecretory conditions like Zollinger-Ellison syndrome.

Q: How quickly does Gastrodex typically start working after the first dose?

A: Regulatory data suggests that rapid symptom relief is often observed after the initial dose. Studies indicate that even a single oral dose can significantly reduce the amount of gastric acid produced in the stomach.

Q: What is the expected duration of the effects of Gastrodex?

A: The mechanism of Gastrodex involves prolonged and sustained inhibition of the acid pumps in the stomach. Official product information notes that with repeated daily administration, the medication is intended to achieve a sustained reduction in gastric acid secretion throughout the day.

Q: Does Gastrodex work by blocking stomach acid, or does it have a different mechanism?

A: Gastrodex (Lansoprazole) is classified as a Proton Pump Inhibitor (PPI), meaning it works directly to block the production of stomach acid. It inhibits the final step of acid formation by targeting the 'proton pump' enzyme in the cells that line the stomach.

Q: How does the action of Gastrodex differ from common antacids or PPIs?

A: As a PPI, Gastrodex provides a potent, long-lasting reduction in acid production itself. This differs from antacids, which only neutralize acid already present in the stomach and offer much shorter relief. Its sustained action is consistent with its intended use for conditions requiring prolonged acid control.

Q: Can Gastrodex cause changes in appetite or weight?

A: Regulatory reports on adverse reactions have included instances of both an increase and a decrease in appetite. Patients who notice persistent changes in appetite or weight are encouraged to discuss this information with a healthcare provider.

Q: Is it normal to feel slightly dizzy or lightheaded when starting Gastrodex?

A: The official safety documents list dizziness as an uncommon adverse reaction associated with the medication. If a patient experiences dizziness or lightheadedness, they may wish to discuss this known potential effect with a healthcare professional.

Q: Are there any foods or beverages that should be strictly avoided while taking Gastrodex?

A: Official product information does not list general food avoidance, but it highlights a specific caution regarding products containing citrate. Citrate, found in certain soft drinks and fruit juices, may increase the absorption of aluminum from Gastrodex, which may pose an increased risk, particularly in individuals with pre-existing kidney impairment.

Q: Can individuals with kidney problems use Gastrodex?

A: Regulatory guidance states that no routine dose adjustment is specified for individuals with reduced kidney function. However, caution is necessary when the drug is taken with certain products. Kidney function is critical when assessing the risk of toxicity from high levels of aluminum or magnesium.

Q: Is Gastrodex a prescription-only medication, or can it be bought over the counter?

A: The active ingredient in Gastrodex (Lansoprazole) is available in both forms. Stronger doses and products intended for treating more severe conditions are typically prescription-only, while lower doses are often available over-the-counter for the short-term treatment of frequent heartburn.

Q: What happens if a dose of Gastrodex is accidentally missed?

A: Official patient instructions state that if a dose is missed, it may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Taking two doses simultaneously to compensate for a missed dose is not recommended by official instructions.

Q: Is there a recommended time of day (morning or evening) to take Gastrodex?

A: Official dosing instructions state that the medication is typically taken once daily before a meal, often in the morning before breakfast. This timing is specified to optimize the drug's absorption.

Q: How is Gastrodex processed by the body (metabolism and excretion)?

A: Regulatory data on pharmacokinetics indicates that Gastrodex is processed (metabolized) extensively in the liver by certain enzyme systems. Once metabolized, the drug is eliminated from the body through both the urine and the feces.

Q: Can Gastrodex cause issues with sleep or fatigue?

A: Official product information lists sleep disturbances, such as insomnia, and general fatigue among the possible adverse reactions. Patients experiencing these issues are encouraged to discuss them with a healthcare professional.

Q: Are there any potential long-term risks associated with taking Gastrodex for many years?

A: Regulatory warnings tied to prolonged use (one year or longer) include an increased risk of bone fracture in the hip, wrist, or spine. Additionally, low blood magnesium levels (Hypomagnesaemia) and the development of Fundic Gland Polyps have been associated with extended daily use.

Q: Why does Gastrodex require a doctor's supervision for use?

A: The prescription versions of Gastrodex are intended for the treatment of serious, diagnosed gastrointestinal conditions, such as ulcers and severe esophagitis. These conditions require professional diagnosis and monitoring to ensure proper healing and management of underlying diseases.

Q: Is Gastrodex considered a prokinetic agent?

A: No, Gastrodex (Lansoprazole) is classified as an anti-secretory agent, specifically a Proton Pump Inhibitor (PPI). It acts to reduce acid production, which is a different function than prokinetic agents, which are drugs that act to increase and improve gastrointestinal motility.

Q: Are there any warnings about driving or operating machinery while on Gastrodex?

A: Official product information contains specific warnings that some side effects, such as visual disturbances or dizziness, may affect a person's ability to drive or operate complex machinery safely. For safety, patients should assess their own reaction to the medicine before driving or operating machinery.

Q: What factors might make Gastrodex less effective for a patient?

A: Official administration instructions emphasize that taking the drug with a full meal may reduce the amount of the drug absorbed, potentially making it less effective. Furthermore, drug interactions that alter stomach pH can interfere with the expected action of the medication.

Q: What kind of monitoring (e.g., blood tests) might be needed while on Gastrodex?

A: For patients expected to be on long-term treatment (one year or longer), official safety information recommends monitoring blood magnesium levels. This is especially important for those also taking other medications known to lower magnesium.

Q: What is the typical course of treatment with Gastrodex?

A: The course of treatment depends entirely on the condition being treated. For example, official indications range from short-term treatment of active duodenal ulcers (e.g., 4 weeks) to a longer course for healing erosive esophagitis (e.g., up to 8-12 weeks).

Q: What does it mean if I don't notice any difference after a week of taking Gastrodex?

A: While many patients experience rapid symptom relief, the full acid-suppressing effect may take a few days or longer to become consistent. In line with patient counseling information, if symptoms do not improve or if they worsen after starting treatment, consulting a healthcare provider for review is recommended.

Q: Does Gastrodex cause changes in bathroom habits, like diarrhea or constipation?

A: Yes, regulatory documents list diarrhea as a common adverse reaction associated with this medication. Constipation has also been reported, though less frequently.

Q: What are the rare but serious side effects I should be aware of with Gastrodex?

A: The official safety profile includes rare but serious events such as severe skin reactions (like Stevens-Johnson Syndrome), certain blood disorders, and a kidney inflammation known as Acute Tubulointerstitial Nephritis. Patients are generally advised that unusual symptoms should be discussed promptly with a medical professional.

Q: Does Gastrodex interact negatively with common pain relievers like ibuprofen or aspirin?

A: Lansoprazole and its related antacid components can interact with many medications by altering their absorption. The general principle for Lansoprazole and many antacids is to separate administration from certain other medications. It is best to consult with a healthcare professional regarding the use of specific over-the-counter pain relievers.

Q: Can Gastrodex be safely taken with supplements like probiotics or vitamins?

A: Regulatory warnings specifically advise separating administration of Lansoprazole from Iron supplements. The interaction profile for general multivitamins and common supplements like probiotics is not detailed in standard prescribing information, making consultation with a healthcare provider or pharmacist necessary.

Q: Does Gastrodex affect how well birth control pills work?

A: Information regarding the specific interaction between Lansoprazole and hormonal contraceptives (birth control pills) is not universally detailed across regulatory documents. This highlights the need for patients to speak with a healthcare professional or pharmacist about all medications they are taking.

Q: Is Gastrodex safe for use in older adults (seniors)?

A: Regulatory documents state that no routine dose adjustment is needed for older adults based on age alone. However, caution is advised for any patient with reduced liver function, which is often a consideration in older populations. A healthcare provider will determine appropriateness on an individual basis.

Q: Is Gastrodex appropriate for use during pregnancy or while breastfeeding?

A: Official restrictions state that use during pregnancy and lactation is not usually recommended because human data is limited and it is not known whether the drug is excreted into breast milk. Any decision regarding use during these periods must be made by a healthcare provider.

Q: What are some of the most common mild side effects reported for Gastrodex?

A: According to official documentation, the most commonly reported reactions include diarrhea, abdominal pain, nausea, and headache. These are generally noted as the most frequent effects observed during clinical trials.

Q: Is it true that Gastrodex can affect the absorption of nutrients like Vitamin B12?

A: The primary nutrient concern highlighted in long-term regulatory warnings is low blood magnesium levels (Hypomagnesaemia). However, this drug class (PPIs) has been associated with effects on the absorption of other nutrients, such as Vitamin B12, over extended periods of use.

How should Gastrodex be stored and disposed of?

Gastrodex (Lansoprazole) must be stored strictly according to the conditions defined in the official regulatory labeling to ensure product stability. The medicine requires storage at controlled room temperature, typically 20 C to 25 C. It is mandatory to protect the capsules from light and moisture by keeping them in the original container with the lid tightly closed.

Crucially, the product must not be frozen as this can compromise the delayed-release formulation. In line with official safety guidelines, the medicine must be stored out of the sight and reach of children.

Disposal of any unused or expired Gastrodex should be done via an authorized medicine take-back program. Regulatory documents instruct that the medicine must not be thrown away via wastewater (flushed) to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Gastrodex found in:

A-Z Index: